You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
石藥集團(01093.HK)與康諾亞訂立戰略聯盟協議

格隆匯9月23日丨石藥集團(01093.HK)發佈公吿,2021年9月22日,公司全資附屬公司津曼特生物與康諾亞-B(02162.HK)全資附屬公司成都康諾亞已訂立戰略聯盟協議。根據協議條款,津曼特及成都康諾亞應共同確定、研究、開發和商業化一種或多種神經系統疾病產品。津曼特主要負責合作產品的臨牀開發和商業化,成都康諾亞主要負責合作產品的臨牀前研發。

津曼特及成都康諾亞已同意建立一個聯合執導委員會,由六名成員組成,由津曼特及康諾亞各提名三名成員。聯合執導委員會應討論並決定(其中包括)與合作產品相關的戰略性及重大事項。

公司相信戰略聯盟將進一步加強集團與康諾亞生物的合作,雙方將進一步利用其各自優勢,協調其資源以共同推動神經系統疾病有關藥物的發展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account